NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-31,17615,35336,250
Cost of Revenue173,797168,435237,939162,644
Gross Profit-139,509-137,259-222,586-126,394
Operating Expenses
Research Development----
Selling General and Administrative-34,45146,52730,842
Non Recurring----
Total Operating Expenses-202,886284,466193,486
Operating Income or Loss--171,710-269,113-157,236
Income from Continuing Operations
Total Other Income/Expenses Net--12,059-10,853299
Earnings Before Interest and Taxes--171,710-269,113-157,236
Interest Expense--14,072-12,965-241
Income Before Tax--183,769-279,966-156,937
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--183,769-279,966-156,937
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--183,769-279,966-156,937
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--183,769-279,966-156,937